The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes
- PMID: 26557226
- PMCID: PMC4636282
The Impact of HbA1c Testing on Total Annual Healthcare Expenditures Among Newly Diagnosed Patients with Diabetes
Abstract
Background: In 2010, diabetes was the seventh leading cause of death in the United States. Diabetes also imposes a huge financial burden on the US economy. In 2009, the American Diabetes Association International Expert Committee recommended the use of the glycated hemoglobin (HbA1c) test as a uniform diagnostic measure to identify patients with diabetes. Although HbA1c is a convenient diagnostic test, it is also more expensive than older tests and could, therefore, have an impact on patients' healthcare expenditures.
Objectives: To determine if HbA1c testing has an impact on total annual healthcare expenditures among newly diagnosed patients with diabetes and to analyze the factors that are associated with the total healthcare expenditures among diabetic patients before and after HbA1c was implemented as a standard diagnostic factor.
Methods: This was an observational, retrospective, cross-sectional study. The Medical Expenditure Panel Survey-Household Component 2009 and 2011 databases were used to form the study cohort of patients with diabetes. The total mean healthcare expenditures among patients with diabetes formed the dependent variable. A proxy variable representing a diagnosis of diabetes with and without the use of HbA1c testing in 2009 and in 2011, respectively, formed the main independent variable along with demographic factors, comorbidities, and healthcare services utilization in both years. A generalized linear regression was conducted to determine the association of HbA1c testing with total diabetes-related healthcare expenditures.
Results: The mean total healthcare expenditure decreased in 2011 compared with 2009. The HbA1c test did not show an association with the total healthcare expenditures versus earlier diabetes-related diagnostic factors. The total expenditures were associated with private insurance, the incidence of a previous heart attack, prescription drug refills, inpatient hospital stays, home care, hospital discharges, and visits to outpatient providers and physicians in both years.
Conclusions: The HbA1c diagnostic factor did not yield any association with diabetes healthcare expenditures. Although the total healthcare expenditures were reduced in 2011 compared with 2009, it cannot be established that the reduction in costs is solely attributed to the implementation of the HbA1c diagnostic criteria. Further research on healthcare expenditures for diabetic patients diagnosed with and without the use of HbA1c testing is warranted to establish any possible association.
Keywords: HbA1c testing; diabetes; diagnostic factor; expenditures; glycated hemoglobin; healthcare utilization.
Figures
Similar articles
-
Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs.J Manag Care Pharm. 2007 Mar;13(2):142-54. doi: 10.18553/jmcp.2007.13.2.142. J Manag Care Pharm. 2007. PMID: 17330975 Free PMC article.
-
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017.Subst Abuse Treat Prev Policy. 2021 Oct 20;16(1):80. doi: 10.1186/s13011-021-00415-5. Subst Abuse Treat Prev Policy. 2021. PMID: 34670580 Free PMC article.
-
Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA.BMJ Open Diabetes Res Care. 2023 Nov;11(6):e003397. doi: 10.1136/bmjdrc-2023-003397. BMJ Open Diabetes Res Care. 2023. PMID: 37914345 Free PMC article.
-
Evidence Brief: Effectiveness of Intensive Primary Care Programs [Internet].Washington (DC): Department of Veterans Affairs (US); 2013 Feb. Washington (DC): Department of Veterans Affairs (US); 2013 Feb. PMID: 27606397 Free Books & Documents. Review.
-
HbA1c Testing Frequency: A Review of the Clinical Evidence and Guidelines [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Sep 26. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Sep 26. PMID: 25411681 Free Books & Documents. Review.
References
-
- Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. 2014. www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed October 11, 2014.
-
- Centers for Disease Control and Prevention. Diabetes Report Card 2012. 2012. www.cdc.gov/diabetes/pubs/pdf/diabetesreportcard.pdf. Accessed June 5, 2014.
-
- American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006; 29(suppl 1): S4–S42. Erratum in: Diabetes Care 2006; 29: 1192. - PubMed
-
- National Diabetes Information Clearinghouse; National Institute of Diabetes and Digestive and Kidney Diseases. The A1C test and diabetes. NIH Publication No 14-7816. March 2014. http://diabetes.niddk.nih.gov/dm/pubs/A1CTest/. Accessed April 2, 2015.
LinkOut - more resources
Full Text Sources